Journal article
Canada's Study of Adherence Outcomes in Patients Receiving Adalimumab: 3-year Results From the COMPANION Study
Abstract
PURPOSE: The aim of this study was to quantify the association between receiving care-coach calls (CCCs), a service provided by a patient-support program (PSP) in Canada, and persistence with and adherence to adalimumab therapy over a 3-year period in patients with immune-related inflammatory diseases (IMID).
METHODS: COMPANION, a longitudinal, retrospective cohort study, was conducted using patient-level data from the PSP combined with those …
Authors
Marshall JK; Bessette L; Shear NH; Lebovic G; Glass J; Millson B; Gaetano T; Gazel S; Latour MG; Laliberté M-C
Journal
Clinical Therapeutics, Vol. 40, No. 6, pp. 1024–1032
Publisher
Elsevier
Publication Date
6 2018
DOI
10.1016/j.clinthera.2018.04.017
ISSN
0149-2918